580 related articles for article (PubMed ID: 32185696)
1. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
Siefried KJ; Acheson LS; Lintzeris N; Ezard N
CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Brensilver M; Heinzerling KG; Shoptaw S
Drug Alcohol Rev; 2013 Sep; 32(5):449-60. PubMed ID: 23617468
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
[TBL] [Abstract][Full Text] [Related]
5. Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Khoramizadeh M; Effatpanah M; Mostaghimi A; Rezaei M; Mahjoub A; Shishehgar S
Daru; 2019 Dec; 27(2):743-753. PubMed ID: 31228128
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatments for methamphetamine addiction: current status and future directions.
Ballester J; Valentine G; Sofuoglu M
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis.
Naji L; Dennis B; Rosic T; Wiercioch W; Paul J; Worster A; Thabane L; Samaan Z
Drug Alcohol Depend; 2022 Mar; 232():109295. PubMed ID: 35066460
[TBL] [Abstract][Full Text] [Related]
11. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
[TBL] [Abstract][Full Text] [Related]
12. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.
Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W
J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for amphetamine dependence: A systematic review.
Lee NK; Jenner L; Harney A; Cameron J
Drug Alcohol Depend; 2018 Oct; 191():309-337. PubMed ID: 30173086
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.
Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried KJ; Lintzeris N
BMJ Open; 2021 May; 11(5):e044696. PubMed ID: 34006547
[TBL] [Abstract][Full Text] [Related]
15. Treatment for amphetamine withdrawal.
Shoptaw SJ; Kao U; Heinzerling K; Ling W
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approaches to methamphetamine dependence: a focused review.
Karila L; Weinstein A; Aubin HJ; Benyamina A; Reynaud M; Batki SL
Br J Clin Pharmacol; 2010 Jun; 69(6):578-92. PubMed ID: 20565449
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
[No Abstract] [Full Text] [Related]
18. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.
Soares E; Pereira FC
Expert Opin Pharmacother; 2019 Dec; 20(18):2273-2293. PubMed ID: 31671001
[No Abstract] [Full Text] [Related]
20. Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N
BMC Psychiatry; 2016 Dec; 16(1):428. PubMed ID: 27905916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
